Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood

References

• Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, . A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200:123–35.
   PubMed Web of Science ®Google Scholar
• Sensken S, Waclawczyk S, Knaupp AS, Trapp T, Enczmann J, Wernet P, . In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy. 2007;9:362–78.
   PubMed Web of Science ®Google Scholar
• Kogler G, Radke TF, Lefort A, Sensken S, Fischer J, Sorg RV, . Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol. 2005;33:573–83.
   PubMed Web of Science ®Google Scholar
• Greschat S, Schira J, Kury P, Rosenbaum C, de Souza Silva MA, Kogler G, . Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev. 2008;17:221–32.
   Google Scholar
• Trapp T, Kogler G, El-Khattouti A, Sorg RV, Besselmann M, Focking M, . Hepatocyte growth factor/c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem. 2008;283:32244–53.
   PubMed Web of Science ®Google Scholar
• Jager M, Degistirici O, Knipper A, Fischer J, Sager M, Krauspe R. Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation. J Bone Miner Res. 2007;22:1224–33.
   Google Scholar
• Buchheiser A, Liedtke S, Looijenga LH, Kogler G. Cord blood for tissue regeneration. J Cell Biochem. 2009;108:762–8.
   Google Scholar
• Yamanaka S. A fresh look at iPS cells. Cell. 2009;137:13–7.
   PubMed Web of Science ®Google Scholar
• Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodriguez-Piza I, Vassena R, . Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell. 2009;5:353–7.
   PubMed Web of Science ®Google Scholar
• Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, . Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell. 2009;5:434–41.
   PubMed Web of Science ®Google Scholar
• Ye Z ZH, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, . Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009; 114:5473–80.
   Google Scholar
• EudraLex. Volume 4: Good Manufacturing Practice (GMP) Guidelines. Directive 91/412/EEC, 2001/20/EC and 2003/94/European Commission, Brussels.
   Google Scholar
• Aktas M, Radke TF, Strauer BE, Wernet P, Kogler G. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax. Cytotherapy. 2008;10:203–11.
   PubMed Web of Science ®Google Scholar
• Rodriguez L, Azqueta C, Azzalin S, Garcia J, Querol S. Washing of cord blood grafts after thawing: high cell recovery using an automated and closed system. Vox Sang. 2004;87:165–72.
   Google Scholar
• Subbanna PK. Mesenchymal stem cells for treating GVHD: in-vivo fate and optimal dose. Med Hypotheses. 2007;69:469–70.
   Google Scholar
• Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, . Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005;11:389–98.
   PubMed Web of Science ®Google Scholar
• Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, . Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307–16.
   PubMed Web of Science ®Google Scholar
• Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol. 2000;28:707–15.
   PubMed Web of Science ®Google Scholar
• Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002;20:530–41.
   PubMed Web of Science ®Google Scholar
• Heiskanen A, Satomaa T, Tiitinen S, Laitinen A, Mannelin S, Impola U, . N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells. 2007;25:197–202.
   PubMed Web of Science ®Google Scholar
• Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica. 2007;92:1208–15.
   PubMed Web of Science ®Google Scholar
• Asher DM. Bovine sera used in the manufacture of biologicals: current concerns and policies of the US Food and Drug Administration regarding the transmissible spongiform encephalopathies. Dev Biol Stand. 1999;99:41–4.
   PubMedGoogle Scholar
• Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting. Bull World Health Organ. 1997;75:505–13.
   PubMed Web of Science ®Google Scholar
• Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, . Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther. 2004;9:747–56.
   PubMed Web of Science ®Google Scholar
• Mannello F, Tonti GA. Concise review. No breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells. 2007;25:1603–9.
   PubMed Web of Science ®Google Scholar
• Shetty P, Bharucha K, Tanavde V. Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells. Cell Biol Int. 2007;31:293–8.
   PubMed Web of Science ®Google Scholar
• Kuznetsov SA, Mankani MH, Robey PG. Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation. 2000;70:1780–7.
   PubMed Web of Science ®Google Scholar
• Meuleman N, Tondreau T, Delforge A, Dejeneffe M, Massy M, Libertalis M, . Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur J Haematol. 2006;76:309–16.
   PubMed Web of Science ®Google Scholar
• Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462–71.
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, Lenta E, . Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol. 2007;211:121–30.
   PubMed Web of Science ®Google Scholar
• Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM, Villaron E, Barbado V, Tabera S, . Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol. 2008;36:1014–21.
   PubMed Web of Science ®Google Scholar
• Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, . Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205:228–36.
   PubMed Web of Science ®Google Scholar
• Muller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, . Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy. 2006;8:437–44.
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, . Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007;47:1436–46.
   PubMed Web of Science ®Google Scholar
• Mizuno N, Shiba H, Ozeki Y, Mouri Y, Niitani M, Inui T, . Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int. 2006;30:521–4.
   PubMed Web of Science ®Google Scholar
• Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, . Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum. 2008;58:501–10.
   PubMed Web of Science ®Google Scholar
• Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol. 2004;32:1212–25.
   PubMed Web of Science ®Google Scholar
• Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007;25:1270–8.
   PubMed Web of Science ®Google Scholar
• Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, . Spontaneous human adult stem cell transformation. Cancer Res. 2005;65:3035–9.
   PubMed Web of Science ®Google Scholar
• Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kogler G. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell. 2007;1:364–6.
   PubMed Web of Science ®Google Scholar
• Liedtke S, Stephan M, Kogler G. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem. 2008;389:845–50.
   PubMedGoogle Scholar
• Jager M, Sager M, Knipper A, Degistirici O, Fischer J, Kogler G, . [In vivo and in vitro bone regeneration from cord blood derived mesenchymal stem cells]. Orthopade. 2004;33:1361–72.
   Web of Science ®Google Scholar
• Fallahi-Sichani M, Soleimani M, Najafi SM, Kiani J, Arefian E, Atashi A. In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. Cell Biol Int. 2007;31: 299–303.
   PubMed Web of Science ®Google Scholar
• Chan SL, Choi M, Wnendt S, Kraus M, Teng E, Leong HF, . Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells. Stem Cells. 2007;25:529–36.
   PubMedGoogle Scholar